Detalhe da pesquisa
1.
Endo-Lysosomal Cation Channels and Infectious Diseases.
Rev Physiol Biochem Pharmacol
; 185: 259-276, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748124
2.
IFN-stimulated metabolite transporter ENT3 facilitates viral genome release.
EMBO Rep
; 24(3): e55286, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652307
3.
Targeting protein-protein interaction interfaces with antiviral N protein inhibitor in SARS-CoV-2.
Biophys J
; 123(4): 478-488, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38234090
4.
Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
J Antimicrob Chemother
; 79(5): 1157-1163, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546761
5.
Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.
J Biomed Sci
; 31(1): 39, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637878
6.
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19.
J Nanobiotechnology
; 22(1): 169, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609998
7.
Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults: A comparative analysis with mRNA vaccines.
J Formos Med Assoc
; 123(3): 340-346, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996322
8.
A Randomized Clinical Trial of 1-Dose vs Accelerated 2-Dose Schedule for Hepatitis A Virus (HAV) Revaccination Among People With Human Immunodeficiency Virus Who Were Nonresponders or Had Seroreversion After Primary HAV Vaccination.
Clin Infect Dis
; 77(4): 529-536, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036404
9.
Contrasting Patterns in the Early Stage of SARS-CoV-2 Evolution between Humans and Minks.
Mol Biol Evol
; 39(9)2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934827
10.
Isolation of Anti-SARS-CoV-2 Natural Products Extracted from Mentha canadensis and the Semi-synthesis of Antiviral Derivatives.
J Nat Prod
; 86(6): 1428-1436, 2023 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37267066
11.
Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine.
Appl Microbiol Biotechnol
; 107(9): 2983-2995, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988669
12.
Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination with a twelve-week interval.
J Formos Med Assoc
; 122(2): 187-191, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987747
13.
Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations.
J Formos Med Assoc
; 122(5): 384-392, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564299
14.
Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan.
J Formos Med Assoc
; 122(1): 78-81, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977867
15.
SARS-CoV-2 infection among healthcare workers whom already received booster vaccination during epidemic outbreak of omicron variant in Taiwan.
J Formos Med Assoc
; 122(5): 376-383, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564300
16.
Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine.
J Formos Med Assoc
; 122(2): 121-131, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127206
17.
Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19.
J Formos Med Assoc
; 122(8): 714-722, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496300
18.
Factors associated with viral rebound among COVID-19 patients receiving oral antivirals.
J Formos Med Assoc
; 122(8): 766-775, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934018
19.
Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry.
Int J Mol Sci
; 24(23)2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38069363
20.
Evolution of Hepatitis B Virus (HBV) Serologic Markers Among Antiretroviral-Naive Young People Living With Human Immunodeficiency Virus Who Had Undergone Neonatal HBV Vaccination and Initiated Antiretroviral Therapy.
Clin Infect Dis
; 75(5): 882-889, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893815